160 related articles for article (PubMed ID: 32356453)
21. Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes.
Lewin R; Amit U; Laufer M; Berger R; Dotan Z; Domachevsky L; Davidson T; Portnoy O; Tsvang L; Ben-Ayun M; Weiss I; Symon Z
Radiat Oncol; 2021 Jun; 16(1):114. PubMed ID: 34162398
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome of palliative radiotherapy for locally advanced symptomatic gastric cancer in the modern era.
Tey J; Choo BA; Leong CN; Loy EY; Wong LC; Lim K; Lu JJ; Koh WY
Medicine (Baltimore); 2014 Nov; 93(22):e118. PubMed ID: 25396330
[TBL] [Abstract][Full Text] [Related]
23. Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17-3).
Saito T; Kosugi T; Nakamura N; Wada H; Tonari A; Ogawa H; Mitsuhashi N; Yamada K; Takahashi T; Ito K; Sekii S; Araki N; Nozaki M; Heianna J; Murotani K; Hirano Y; Satoh A; Onoe T; Watakabe T; Shikama N
Gastric Cancer; 2022 Mar; 25(2):411-421. PubMed ID: 34580795
[TBL] [Abstract][Full Text] [Related]
24. Verification of the Utility of Palliative Radiotherapy for Hemostasis of Gastric Cancer Bleeding: a Case Control Study.
Sugita H; Sakuramoto S; Mihara Y; Matsui K; Nishibeppu K; Ebara G; Fuijta S; Fujihata S; Oya S; Miyawaki Y; Sato H; Horita Y; Hamaguchi T; Noda SE; Kato S; Hirano Y; Okamoto K; Koyama I
J Gastrointest Cancer; 2022 Jun; 53(2):420-426. PubMed ID: 33754255
[TBL] [Abstract][Full Text] [Related]
25. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
Wu X; Hu X; Chen J; He L
Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
[TBL] [Abstract][Full Text] [Related]
26. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
27. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity.
Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581
[TBL] [Abstract][Full Text] [Related]
28. Results of re-irradiation for pelvic recurrence in anorectal cancer patients.
Park Y; Kim K; Park HJ; Jeong SY; Park KJ; Han SW; Kim TY; Chie EK
Br J Radiol; 2019 May; 92(1097):20180794. PubMed ID: 30864822
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of diffusion-weighted magnetic resonance imaging for evaluating the effect of hemostatic radiotherapy for unresectable gastric cancer.
Tanaka O; Omatsu T; Kariya S; Maejima R; Taniguchi T; Ono K; Kunishima Y; Matsuo M
Clin J Gastroenterol; 2019 Jun; 12(3):269-273. PubMed ID: 30446953
[TBL] [Abstract][Full Text] [Related]
30. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
[TBL] [Abstract][Full Text] [Related]
31. Interventions for the treatment of metastatic extradural spinal cord compression in adults.
George R; Jeba J; Ramkumar G; Chacko AG; Tharyan P
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006716. PubMed ID: 26337716
[TBL] [Abstract][Full Text] [Related]
32. High-Dose Thoracic Re-irradiation of Lung Cancer Using Highly Conformal Radiotherapy Is Effective with Acceptable Toxicity.
Hong JH; Kim YS; Lee SW; Lee SJ; Kang JH; Hong SH; Hong JY; Cheon G
Cancer Res Treat; 2019 Jul; 51(3):1156-1166. PubMed ID: 30514067
[TBL] [Abstract][Full Text] [Related]
33. Whole abdominal field versus standard field radiotherapy plus concomitant and adjuvant chemotherapy for patients with locally advanced gastric cancer.
Orhan O; Eroglu C; Kaplan B; Ucar K; Altinbas M; Ozkan M; Unal D; Yildiz OG; Soyuer S
J Radiat Res; 2011; 52(2):168-75. PubMed ID: 21343682
[TBL] [Abstract][Full Text] [Related]
34. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
[TBL] [Abstract][Full Text] [Related]
35. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
[TBL] [Abstract][Full Text] [Related]
36. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
Jereczek-Fossa BA; Rojas DP; Zerini D; Fodor C; Viola A; Fanetti G; Volpe S; Luraschi R; Bazani A; Rondi E; Cattani F; Vavassori A; Garibaldi C; Alessi S; Pricolo P; Petralia G; Cozzi G; De Cobelli O; Musi G; Orecchia R; Marvaso G; Ciardo D
Br J Radiol; 2019 Feb; 92(1094):20180494. PubMed ID: 30379566
[TBL] [Abstract][Full Text] [Related]
37. Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?
Henkenberens C; Meinecke D; Michael S; Bremer M; Christiansen H
Strahlenther Onkol; 2015 Nov; 191(11):845-54. PubMed ID: 26307627
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis.
Jablonska PA; Cambeiro M; Gimeno M; Aramendía JM; Mínguez JA; Alcázar JL; Aristu JJ; Calvo FA; Martínez-Monge R
Clin Transl Oncol; 2021 Sep; 23(9):1934-1941. PubMed ID: 33835408
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of palliative radiotherapy and chemo-radiotherapy for unresectable gastric cancer demonstrating bleeding and obstruction.
Hiramoto S; Kikuchi A; Tetsuso H; Yoshioka A; Kohigashi Y; Maeda I
Int J Clin Oncol; 2018 Dec; 23(6):1090-1094. PubMed ID: 30019177
[TBL] [Abstract][Full Text] [Related]
40. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]